Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Hepatology. 2016 Nov;64(5):1743-1756. doi: 10.1002/hep.28780. Epub 2016 Sep 30.
Hepatocytes are dynamic cells that, upon injury, can alternate between nondividing differentiated and dedifferentiated proliferating states in vivo. However, in two-dimensional cultures, primary human hepatocytes (PHHs) rapidly dedifferentiate, resulting in loss of hepatic functions that significantly limits their usefulness as an in vitro model of liver biology, liver diseases, as well as drug metabolism and toxicity. Thus, understanding the underlying mechanisms and stalling of the dedifferentiation process would be highly beneficial to establish more-accurate and relevant long-term in vitro hepatocyte models. Here, we present comprehensive analyses of whole proteome and transcriptome dynamics during the initiation of dedifferentiation during the first 24 hours of culture. We report that early major rearrangements of the noncoding transcriptome, hallmarked by increased expression of small nucleolar RNAs, long noncoding RNAs, microRNAs (miRNAs), and ribosomal genes, precede most changes in coding genes during dedifferentiation of PHHs, and we speculated that these modulations could drive the hepatic dedifferentiation process. To functionally test this hypothesis, we globally inhibited the miRNA machinery using two established chemically distinct compounds, acriflavine and poly-l-lysine. These inhibition experiments resulted in a significantly impaired miRNA response and, most important, in a pronounced reduction in the down-regulation of hepatic genes with importance for liver function. Thus, we provide strong evidence for the importance of noncoding RNAs, in particular, miRNAs, in hepatic dedifferentiation, which can aid the development of more-efficient differentiation protocols for stem-cell-derived hepatocytes and broaden our understanding of the dynamic properties of hepatocytes with respect to liver regeneration.
miRNAs are important drivers of hepatic dedifferentiation, and our results provide valuable information regarding the mechanisms behind liver regeneration and possibilities to inhibit dedifferentiation in vitro. (Hepatology 2016;64:1743-1756).
肝细胞是具有活力的细胞,在受到损伤时,它们可以在体内非分裂分化状态和去分化增殖状态之间交替。然而,在二维培养中,原代人肝细胞(PHH)会迅速去分化,导致肝功能丧失,这极大地限制了它们作为肝生物学、肝疾病以及药物代谢和毒性的体外模型的用途。因此,了解去分化过程的潜在机制和阻止其发生将非常有利于建立更准确和相关的长期体外肝细胞模型。在这里,我们对培养起始后 24 小时内去分化过程中非编码转录组的整体蛋白质组和转录组动态进行了全面分析。我们报告说,早期非编码转录组的主要重排,其特征是小核仁 RNA、长非编码 RNA、microRNAs(miRNAs)和核糖体基因的表达增加,先于 PHH 去分化过程中大多数编码基因的变化,我们推测这些调节可能会驱动肝去分化过程。为了对该假说进行功能验证,我们使用两种已建立的化学上不同的化合物,吖啶黄素和聚赖氨酸,对 miRNA 机制进行了全局抑制。这些抑制实验导致 miRNA 反应显著受损,最重要的是,对肝脏功能重要的肝基因下调显著减少。因此,我们提供了强有力的证据表明非编码 RNA,特别是 miRNAs,在肝去分化中具有重要作用,这有助于开发更有效的干细胞源性肝细胞分化方案,并拓宽我们对肝细胞动态特性的理解,特别是在肝再生方面。
miRNAs 是肝去分化的重要驱动因素,我们的结果为肝再生背后的机制以及在体外抑制去分化的可能性提供了有价值的信息。(《肝脏病学》2016 年;64:1743-1756)